Microbiology & Virology

Karin Moelling was born in Northern Germany, trained as a physicist specialized in Nuclear Physics. She was trained at Berkeley, University of California, in Molecular Biology and Biochemistry. She took her PhD at the Max-Planck-Institute for Virology at Tübingen, Germany, and her Habilitation at the University of Giessen in Biophysics. She worked at the Robert Koch-Institute in Berlin, the Max-Planck-Institute for Molecular Genetics in Berlin. In 1993 she became Director and Professor of the Institute for Medical Virology at the University of Zurich and Head of the Viral Diagnostics Department of the University Hospital, which she increased 15-fold. She had to retire there and is still affiliated with the University of Zurich and the Max-Planck-Institute for Molecular Genetics in Berlin. She was Fellow at the Institute of Advanced Study at Berlin 2008/2009 and became Vice President of the Fellow Club.

Viruses, in particular retroviruses, and cancer, from molecular mechanisms to drug design. Replication of HIV, discovery of the retroviral RNase H, development of antiretroviral mechanisms driving HIV into suicide, and various oncogenes such as identification of Myc and Myb as nuclear transcription factors, and discovery of the Mil/Raf kinase as retroviral oncogene. Interest in signal transduction in normal and tumor cells, gene regulation, cell-cycle, transcription factors, PDZ domains, scaffold proteins, oncogenes in leukemias, lymphomas, cancer, gene medicine/therapy, vaccines, HIV/AIDS, Influenza, viruses in immune-suppression, antiviral drug design, silencing by siDNA. biotechnology, non-coding RNA, endogenous viruses, evolution of viruses.

Giulio Tarro graduated from Medicine School, Naples University (1962). Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus, 2006 -. Since 2007 Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization lifetime achievement award (2010). His researches have been concerned with the characterization of specific virus-induced tumour antigens, which were the "finger-prints" left behind in human cancer. Achievements include patents in field; discovery of Respiratory Syncytial Virus in infant deaths in Naples and of tumor liberated protein as a tumor associated antigen, 55 kilodalton protein overexpressed in lung tumors and other epithelial adenocarcinomas.

His basic researches have been concerned with antigens induced early during the replication cycle of human herpesviruses. Another study has involved the identification, isolation and characterization of specific virus-induced tumour antigens, which were the “finger-prints” left behind in human cancer. Achievements include patents in field; discovery of Respiratory Syncytial Virus in infant deaths in Naples and of tumor liberated protein as a tumor associated antigen, 55 kilodalton protein overexpressed in lung tumors and other epithelial adenocarcinomas.

Alessandro Camporese, MD, is the Director of Microbiology and Virology Department, located in S.Maria degli Angeli Hospital (SMA), Pordenone, one of the main Microbiology and Virology Lab in the North East of Italy. The SMA Microbiology and Virology Lab is a high technology, high throughput Microbiology and Virology Hub operating in a metropolitan area with five other Hospitals (including a National Cancer Institute), with a total of about 1200 beds, as well as several outpatient care facilities, which are all headed by SMA Hospital. Dr.Camporese research interests focus mainly on automation in microbiology and virology and on molecular diagnosis of infections.

Microbiology and Virology

Education University of Bristol, England -1965 - Bachelor of Veterinary Science with honors University of Guelph, Canada -1967 - M.Sc. University of Guelph, Canada - 1970 - Ph.D. Walter and Eliza Hall Institute of Medical Research, Australia – 1970-72 – Postdoctoral research University of Bristol, England - 1997 - D.Sc. Teaching Immunology Funding Two RO1 grants from National Institutes of Health Professional Activities Trained > 75 graduate students and postdoctoral fellows Received several awards for research accomplishments most notably Alcon Award for outstanding contributions to vision research, 2000 and Medal of Merit, Warsaw University of Life Sciences, 2014. Recipient of Fogarty Senior International Fellowship and Alexander Von Humboldt Fellowship Been extensively involved in reviewing NIH grants since 1978 which includes 3 times as a permanent member of study section and once as chairman Member of Faculty of 1000 since its inception Coorganizer of several conferences Member of editorial board and reviewer of many journals Member of AAI and ASM for >30 years 2017 UTIA Institute Professer - UT Institute of Agriculture

Prof Barry have research interest in the field of infectious disease and has focused on viral immunology and immunopathology. We have mainly studied herpes simplex virus (HSV) infection in mice both with a view to devising successful vaccines and more particularly to determine how HSV causes tissue damage in critical tissues such as the eye and nervous system.

Vladimir Zajac has completed his PhD. in 1982 at the Cancer Research Institute of Slovak Academy of Sciences in Bratislava (Slovakia), where he was from 1996 to 2010 the head of Department of Cancer Genetics. He joined the Medical Faculty of the Comenius University as Associate Professor of Genetics in 2008. He has published 59 papers mostly in reputed journals and he was editor of the book "Microbes, Viruses and Parasites in AIDS Process"

AIDS, HIV, Cancer, Genetics

After obtaining my Academic Degree in Molecular Biology and Biochemistry at the Autónoma University, Madrid, Spain, I initiated my Ph.D. Student Program at the Carlos III Health Institute, Majadahonda. My initial field of research was the study of HTLV infections among HIV-1 infected patients. I also initiated some epidemiologic research on HIV infections, including HIV-1 group O and HIV-2. I moved to the Laboratory of Molecular Virology, CBER, Food and Drug Administration, Bethesda, MD, USA, as a Post Doctoral Fellow (1995-2000) and developed my work on molecular epidemiology of HTLV and HIV, and viral tropism. Then I joined the Immunovirology Laboratory at the Virgen del Rocío University Hospital, Seville, Spain, as an independent researcher (2000-2008). I focused my research on immune recovery of HIV-1-infected patients. Then I moved to Ramon y Cajal University Hospital in Madrid to follow my research on HIV-1 immunopathology and continuing the research on HTLV-1/2 infections (2008- ) running the Laboratory of Molecular Virology within the Infectious Diseases Department.. I also coordinate the subject Methods in Virology included in the Master of Virology at the Complutense University (UCM) in Madrid. I am also member of the Editorial Board of Scientific Journals such as Medicine, Current Immunology Reviews, and The Open Immunology Journal. I collaborate as a reviewer for human resources and projects in Spanish National Evaluation Agencies (ANEP, FIS).

Molecular Biology, Biochemistry, HIV infections, HTLV infections,

Dr. Zeedan obtained his PhD in Virology from Cairo University, Egypt. He has experience in modern & classical immunodiagnostic techniques such as different types of ELISA , IFAT, RIA, Dot ELISA, HI, CFT, AGPT, SPA agglutination test, SNT & Dot blot hybridization. He is also interested in the diagnosis of animals viruses by different Molecular techniques. His skills include protein and molecular characterization, RNA analysis, Bioinformatic studies, viral and bacterial cell culturing methods and virus quantification assays.

Molecular Typing and Epidemiological Studies of Viruses and Bactria of Animal Origin with Special Interest of Antibacterial and Antiviral Agents